Tyler Whitney

Tyler Whitney is a Co-Founder and CFO at Spectra Plasmonics, whose mission is to create better access to high quality molecular analysis for human health. Spectra’s flagship product, Amplifi ID, is used by public health organizations in North America to test street drugs in their communities. This gives them real time data to combat the overdose crisis more proactively. Tyler co-founded Spectra while completing a dual degree in Commerce and Economics at Queen’s University.